文献速递青光眼

眼压调节泵施加负压降低正常眼压性青光眼眼压:HERCULES研究

Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES Study.
PubMed 文献 · Am J Ophthalmol · 2025-03-25

前瞻性多中心随机对照试验纳入眼压≥12且≤21 mm Hg的正常眼压性青光眼受试者,一眼随机接受夜间负压治疗、对侧眼对照,治疗1年。第52周日间眼压下降≥20%的研究眼占88.3%(53眼)vs对照眼1.7%(1眼),夜间对应为96.7%(58眼)vs 5.0%(3眼),未报告严重不良事件。

要点

  • 第52周日间眼压下降≥20%:研究眼88.3%(53眼)vs对照眼1.7%(1眼)
  • 第52周夜间眼压下降≥20%:研究眼96.7%(58眼)vs对照眼5.0%(3眼)
  • 夜间平均眼压由基线20.4±2.5 mm Hg降至12.4±2.7 mm Hg,降幅8.0 mm Hg(39.1%)

核心结论

  • 眼压调节泵可安全有效地降低正常眼压性青光眼患者的日间和夜间眼压。

研究设计与样本

  • 前瞻性、多中心、设盲、随机、对侧眼对照试验,共11个中心随机186眼。
  • 受试者为眼压≥12 mm Hg且≤21 mm Hg的正常眼压性青光眼患者,每例一眼随机接受负压治疗,对侧眼为对照。
  • 受试者夜间佩戴装置1年,所施负压按基线眼压减去参考眼压6 mm Hg设定。
  • 120眼完成52周全部访视且无方案偏离。

主要发现

  • 主要终点第52周日间眼压下降≥20%:研究眼88.3%(n=53)vs对照眼1.7%(n=1)。
  • 次要终点第52周夜间眼压下降≥20%:研究眼96.7%(n=58)vs对照眼5.0%(n=3)。
  • 探索性分析第52周夜间平均眼压由基线20.4±2.5 mm Hg降至12.4±2.7 mm Hg,降幅8.0 mm Hg(39.1%)。
  • 未发生严重不良事件;最常见不良事件为眼睑水肿(研究眼11.8% vs对照眼1.1%)和眶周水肿(研究眼12.9% vs对照眼1.1%)。

关键数值与推荐

  • 主要疗效终点为第52周日间眼压下降≥20%的眼比例。
  • 次要终点为第52周夜间眼压下降≥20%的眼比例。
  • 探索性终点包括诊室和睡眠实验室的平均眼压降幅。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the safety and intraocular pressure (IOP)-lowering efficacy of the ocular pressure adjusting pump in subjects with normal-tension glaucoma (NTG). DESIGN: Prospective, multicenter, masked, randomized, fellow-eye controlled trial. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: Subjects with NTG with an IOP ≥12 mm Hg and ≤21 mm Hg were enrolled. One eye of each subject was randomized to receive negative pressure application; the fellow eye served as a control. METHODS: Subjects wore the device overnight for 1 year and the applied negative pressure was programmed by subtracting a reference IOP of 6 mm Hg from the baseline IOP. MAIN OUTCOME MEASURES: The primary effectiveness endpoint was the proportion of eyes achieving an IOP reduction ≥20% at Week 52 during the day. The secondary endpoint was the proportion of eyes achieving a nocturnal IOP reduction ≥20% at Week 52. Exploratory endpoints included mean IOP reduction in clinic and in the sleep lab. RESULTS: A total of 186 eyes were randomized across 11 sites. 120 eyes successfully completed all visits across 52 weeks without protocol deviations. At Week 52, 88.3% (n = 53) of study eyes vs 1.7% (n = 1) of control eyes met the primary endpoint. For the secondary endpoint, 96.7% (n = 58) of study eyes vs 5.0% (n = 3) met the endpoint. For exploratory IOP analysis, the mean nocturnal IOP reduction at Week 52 was 8.0 mm Hg (39.1%) from a baseline of 20.4 ± 2.5 mm Hg to 12.4 ± 2.7 mm Hg. There were no serious adverse events. The most commonly reported adverse events were lid (11.8% study, 1.1% control) and periorbital edema (12.9%, 1.1%). CONCLUSIONS: The ocular pressure adjusting pump safely and effectively lowers both daytime and nocturnal IOP in patients with NTG.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ferguson TJ, Samuelson TW, Herndon L, et al. Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES Study. Am J Ophthalmol. 2025. PMID: 40147597. doi:10.1016/j.ajo.2025.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。